Grim19 Antibodies

Santa Cruz Biotechnology provides a broad selection of Grim19 monoclonal antibodies for advanced research in cellular and molecular biology. Grim19 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Grim19, a critical component of the mitochondrial complex I, plays a significant role in regulating apoptosis and cellular energy metabolism. The function of Grim19 is essential for maintaining cellular homeostasis and has implications in various diseases, including cancer and neurodegenerative disorders. Understanding Grim19's role can provide insights into therapeutic targets and strategies for disease intervention. Researchers worldwide utilize Grim19 monoclonal antibodies to investigate cellular signaling pathways and molecular mechanisms. Current studies focusing on Grim19 continue to reveal new aspects of mitochondrial function and cellular regulation. Characterization and consistent performance of Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to scientific understanding of cellular processes and disease mechanisms.